This content is from:xinyabo体育
默克公司成为激进的目标吗?一个对冲Fund Thinks So
Suvretta Capital Management — which is not an activist investor — lays out the case in its second quarter letter.
Is Merck an attractive target for activists?At least one hedge fund firm thinks so.In its second-quarter letter, dated August 17 and obtained by Institutional Investor, Suvretta Capital Management — which is not an activist hedge fund — makes the case for the drug giant winding up in the cross-hairs of
To continue reading,subscribe nowto Premium Journalism. Already a subscriber?Login.